Efficient separation of electron–hole pairs is vitally crucial to enhancing the analytical performance of paper-based photoelectrochemical (PEC) bioanalysis. Herein, a simple but effective strategy is developed to modulate the effective separation of photogenerated electrons and holes via introducing a polar charge carriers-created (PCC) electric field induced by a classical perovskite ferroelectric BaTiO3 (BTO). By inserting it between the n-type WO3 nanoflakes and p-type Cu2O (WO3 nanoflakes/BTO/Cu2O), the photoelectrode is endowed with a renewable PCC electric field, as a sustaining driving force, to guarantee the realization of directional separation of charge carrier (DSCC) strategy in PEC bioanalysis. The enduring PCC electric field can attract the electrons of Cu2O and holes of WO3, respectively, thereby regulating the directional migration of charge carriers and achieving an enhanced PEC photocurrent for the ultrasensitive quantification based on the highly efficient separation of electron–hole pairs. Consequently, with respect to WO3 nanoflakes/Cu2O and WO3 nanoflakes photoelectrode, the polarized WO3 nanoflakes/BTO/Cu2O photoelectrode exhibits 1.7 and 10.9 times higher photocurrent density, respectively. Benefiting from this, the prominent photocurrent density is obtained which is extremely beneficial for enhancing the sensitivity of PEC bioanalysis. Ultimately, the ultrasensitive detection of model prostate specific antigen (PSA) is realized and presents a linear range of 0.1 pg/mL–50 ng/mL with the detection limitation of 0.036 pg/mL. This work provides the basis for understanding the role of the polarized electric field induced by ferroelectric in tuning the charge separation as well as insights on strategies for constructing high-performance paper-based PEC bioanalysis.

There is an increasing body of evidence for the involvement of inflammation and brain-derived neurotrophic factor (BDNF) in depression. Ginkgo extract EGb761 possesses anti-inflammatory, anti-oxidative, anti-arteriosclerosis, and neuroprotective activities. But the effect of EGb761 on lipopolysaccharide (LPS)-induced depressive-like behaviours has not been investigated. The present study mainly aimed to examine the antidepressant-like activities of Ginkgo extract EGb761 in mice after lipopolysaccharide administration. C57BL/6J male mice were pretreated with EGb761 or vehicle for 10 days. Then, a single dose of lipopolysaccharide was intraperitoneally administrated to mice to induce depressive-like behaviour. Forced swim test (FST), tail suspension test (TST), and sucrose preference test were performed to evaluate the depressive-like behaviours of the mice. Locomotor activity was examined by open field test. Levels of brain-derived neurotrophic factor, TNF-α, IL-1β, IL-6, IL-17A, and IL-10 in hippocampus tissue homogenate were measured using ELISA kits. We found that LPS administration induced significant depressive-like behaviours, higher levels of tumour necrosis factor α (TNF-α), interleukin (IL) 1β, IL-6, and IL-17A, but lower levels of BDNF and IL-10 in hippocampus tissue homogenate of the mice from the vehicle group compared to the control mice. Pretreatment with middle dose (100 mg/kg/day) and high dose (150 mg/kg/day) of EGb761 significantly attenuated depressive-like behaviours without affecting spontaneous locomotor activity, and inhibited the changes of hippocampal cytokines and BDNF induced by LPS administration. We conclude that EGb761 has antidepressant-like activities in mice with LPS-induced depressive-like behaviours.

A new series of highly ordered 3D hierarchical Co3O4@MnO2 core–shell hybrid materials was developed by a simple in situ self-assembly strategy for two typical energy applications in DSSCs and AP decomposition with superior performances.

Curcumin (Cur), an active phenolic compound in Zingiberaceae, is a fat-soluble natural medicine with a significant curative effect on Alzheimer’s disease (AD). However, Cur has low water solubility, resulting in low bioavailability. In this study, a new type of multifunctional nano-liposome was developed and designed to increase the bioavailability of Cur. Using hyaluronic acid (HA) as the carrier, a transferrin-hyaluronic acid-curcumin (Tf-HACur) nanoliposome was prepared by loading transferrin (Tf) targeting agent and Cur to treat AD. Tf-HA-Cur has very low cytotoxicity. Behavioral and molecular results show that Tf-HA-Cur can cross the blood-brain barrier and effectively treat AD. The nanoliposome provides a new strategy for the delivery of drugs.